Company Monitoring Page for Amarin

latest headlines for company on cafepharma

ESC 2019 – Amarin hopes for guideline boost despite regulatory delay
EP Vantage
Tue, 09/3/19 - 10:54 am
Tags:
Amarin, Vascepa, ESC, European Society of Cardiology
Amarin's Vascepa buzzkill: FDA stalls label review with surprise panel meeting
Fierce Pharma
Thu, 08/8/19 - 11:36 pm
Tags:
Amarin, Vascepa, advisory panels, FDA
Amarin boosted as another milestone to the FDA’s big Vascepa decision flies by with no sign of an AdCom
Endpoints
Wed, 07/31/19 - 10:30 am
Tags:
FDA, Amarin, Vascepa, advisory panels, earnings
Amarin: Is a Buyout Really Off the Table?
Yahoo/Motley Fool
Sun, 07/21/19 - 04:17 pm
Tags:
Amarin, M&A
Acasti sits pretty as raise brings $400M for Amarin
BioWorld
Fri, 07/19/19 - 07:24 pm
Tags:
Amarin, Vascepa, FDA, Acasti
Amarin raises sales guidance for heart drug Vascepa, hires more sales reps for larger marketing push
Stat
Tue, 07/2/19 - 12:20 pm
Tags:
Amarin, Vascepa, FDA, hirings, drug reps
Amarin gets a boost from the FDA as regulators promise speedy Vascepa decision — but what about that panel review?
Endpoints
Wed, 05/29/19 - 10:12 am
Tags:
Amarin, Vascepa, FDA
Amarin defends Vascepa's CV-prevention data against supplement makers eager to cash in
Fierce Pharma
Wed, 05/8/19 - 10:51 am
Tags:
Amarin, Vascepa
These 6 biotech stocks are promising takeover targets
Marketwatch
Thu, 05/2/19 - 11:33 am
Tags:
M&A, Sarepta Therapeutics, Amarin, Intercept Pharmaceuticals, Immunomedics, Alder Biopharmaceuticals, Biogen
Amarin takes application to expand Vascepa label to the FDA as M&A chatter heats up
Endpoints
Fri, 03/29/19 - 10:02 am
Tags:
Amarin, Vascepa, FDA, M&A
Diabetes group nods to Vascepa, sending Amarin stock higher
Biopharma Dive
Thu, 03/28/19 - 07:59 pm
Tags:
ADA, Vascepa, Amarin, diabetes
Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
Stat
Mon, 03/18/19 - 12:14 pm
Tags:
Amarin, Vascepa, American College of Cardiology
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Tags:
Roche, SAGE Therapeutics, Ligand Pharmaceuticals, brexanolone, Tecentriq, Jazz Pharmaceuticals, JZP-110, Sanofi, Lexicon Pharmaceuticals, Zynquista, PhaseBio, AstraZeneca, Amarin, Leap Therapeutics, Strongbridge
ACC 2019 preview – Bayer hopes for heart failure panache
EP Vantage
Tue, 03/12/19 - 10:15 am
Tags:
Bayer, heart failure, Amarin, Esperion, ACC, Vascepa, bempedoic acid
Is Amarin Sitting on a Goldmine?
Motley Fool
Thu, 02/28/19 - 09:18 pm
Tags:
Vascepa, Amarin
Would Pfizer Shareholders Win With an Acquisition of Amarin?
Motley Fool
Sun, 01/20/19 - 03:26 pm
Tags:
Pfizer, Amarin, M&A
Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs
Fierce Pharma
Sat, 01/12/19 - 11:37 am
Tags:
JPMHC 2019, M&A, Pfizer, Biogen, Amarin
The winners and losers from JPM 2019
Biopharma Dive
Fri, 01/11/19 - 11:51 am
Tags:
JPMHC 2019, Loxo Oncology, SAGE Therapeutics, Amarin, FDA, M&A
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
Thu, 01/10/19 - 08:48 pm
Tags:
JPMHC 2019, SAGE Therapeutics, SAGE-217, Mersana, Novavax, Denali Therapeutics, AstraZeneca, Amarin, FDA, government shutdown
Pharma's 2019 Prognosis Hinges on These Key Themes
Bloomberg
Wed, 01/2/19 - 09:48 pm
Tags:
drug pricing, Amarin, Vascepa, IPOs, cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.